Bayer HealthCare announces the launch of Canesten Sensicare for women

Press release

Published May 10th, 2011 - 10:45 GMT

Bayer's latest intimate care products for women, Canesten Sensicare

The Consumer Care Division of Bayer HealthCare LLC announced the launch of Canesten Sensicare, the latest addition to Canesten’s worldwide product portfolio in this region. The launch coincides with world renowned professor Andrew E. Czeizel’s lecture tour of the Middle East on Canesten’s and Elevit superior research edge in healthy pregnancy and reduction of babies abnormalities at birth.

Andrew E. Czeizel, MD, PhD is the world’s leading authority in the field of Folic Acid and Birth Defects Prevention and has served as director of the WHO Collaborating Centre for the Community Control of Hereditary Diseases. He will present data and discuss findings on preterm birth reduction after clotrimazole (Canesten) treatment during pregnancy in an exclusive lecture series for the Gynaecologists in Dubai on 06 May 2011 and in Beirut on 07 May 2011 which is endorsed by Lebanese Society of OBS and Gynaecology. The findings, based on a study of 38,000 (thirty eight thousand) newborn infants, reveal that mothers who received clotrimazole during pregnancy including in the first trimester, showed a significant reduction in preterm births.

Clotrimazole was registered in Germany for the first time in 1973 and launched in the market under the brand name Canesten.

Canesten advocates a pro-active approach towards prevention of female yeast infection and its range of 36 products is marketed in more than 90 countries all over the globe.

SensiCare is the latest intimate cleansing product containing Lactic Acid to maintain and support the natural balance and Lotus Extract for its calming and soothing properties. It is a Preservative Free, both gynaecologically and dermatologically tested formulation and proven to be hypoallergenic.

The second topic of the lecture will be discussing the findings of his study about the key role of folic acid containing multivitamin supplements in delivering a healthy baby and reducing the risk of babies’ abnormalities at birth.

Elevit is the prenatal supplement clinically proven to be beneficial for the development of a healthy baby. It is specifically formulated with the right level of vitamins, minerals and trace elements to help meet nutritional requirements during pregnancy and nursing.

Background Information

Bayer

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2017, the Group employed around 99,800 people and had sales of EUR 35.0 billion. Capital expenditures amounted to EUR 2.4 billion, R&D expenses to EUR 4.5 billion.